These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 9242566)
1. Outbreak of hepatitis C virus infection in patients with hematologic disorders treated with intravenous immunoglobulins: different prognosis according to the immune status. Rossi G; Tucci A; Cariani E; Ravaggi A; Rossini A; Radaeli E Blood; 1997 Aug; 90(3):1309-14. PubMed ID: 9242566 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. Bjøro K; Frøland SS; Yun Z; Samdal HH; Haaland T N Engl J Med; 1994 Dec; 331(24):1607-11. PubMed ID: 7526215 [TBL] [Abstract][Full Text] [Related]
3. Outbreak of acute hepatitis C following the use of anti-hepatitis C virus--screened intravenous immunoglobulin therapy. Healey CJ; Sabharwal NK; Daub J; Davidson F; Yap PL; Fleming KA; Chapman RW; Simmonds P; Chapel H Gastroenterology; 1996 Apr; 110(4):1120-6. PubMed ID: 8613001 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus infection in hypogammaglobulinemic patients receiving long-term replacement therapy with intravenous immunoglobulin. Taliani G; Guerra E; Rosso R; Badolato MC; Luzi G; Sacco G; Lecce R; De Bac C; Aiuti F Transfusion; 1995 Feb; 35(2):103-7. PubMed ID: 7825204 [TBL] [Abstract][Full Text] [Related]
5. Laboratory diagnosis and molecular epidemiology of an outbreak of hepatitis C virus infection among recipients of human intravenous immunoglobulin in Spain. Echevarría JM; León P; Domingo CJ; López JA; Elola C; Madurga M; Salmerón F; Yap PL; Daub J; Simmonds P Transfusion; 1996 Aug; 36(8):725-30. PubMed ID: 8780668 [TBL] [Abstract][Full Text] [Related]
6. Clinical and virologic features of hepatitis C virus infection associated with intravenous immunoglobulin. Jonas MM; Baron MJ; Bresee JS; Schneider LC Pediatrics; 1996 Aug; 98(2 Pt 1):211-5. PubMed ID: 8692620 [TBL] [Abstract][Full Text] [Related]
7. Unusual course of the hepatitis C virus infection in one patient diagnosed of common variable immunodeficiency. Múñoz FJ; de la Calle A; Giménez MJ; González J; Conde J Allergol Immunopathol (Madr); 1995; 23(6):263-6. PubMed ID: 8579003 [TBL] [Abstract][Full Text] [Related]
8. Clinical outcome of hypogammaglobulinaemic patients following outbreak of acute hepatitis C: 2 year follow up. Christie JM; Healey CJ; Watson J; Wong VS; Duddridge M; Snowden N; Rosenberg WM; Fleming KA; Chapel H; Chapman RW Clin Exp Immunol; 1997 Oct; 110(1):4-8. PubMed ID: 9353141 [TBL] [Abstract][Full Text] [Related]
9. Transmission of hepatitis C virus in allografted patients: use of viral genotyping as an epidemiological marker. Gangneux JP; Traineau R; Tuveri R; Ravera N; Bureau C; Gluckman E; Benbunan M; Loiseau P Bone Marrow Transplant; 1996 Dec; 18(6):1131-3. PubMed ID: 8971383 [TBL] [Abstract][Full Text] [Related]
10. Late seroconversion and high chronicity rate of hepatitis C virus infection in patients with hematologic disorders. Gruber A; Norder H; Magnius L; Rotzén M; Rubio C; Grillner L; Björkholm M Ann Oncol; 1993 Mar; 4(3):229-34. PubMed ID: 7682437 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus infection and autoimmune thrombocytopenic purpura. Pawlotsky JM; Bouvier M; Fromont P; Deforges L; Duval J; Dhumeaux D; Bierling P J Hepatol; 1995 Dec; 23(6):635-9. PubMed ID: 8750160 [TBL] [Abstract][Full Text] [Related]
12. Follow-up of four HIV-infected individuals after administration of hepatitis C virus and GBV-C/hepatitis G virus contaminated intravenous immunoglobulin: evidence for HCV but not for GBV-C/HGV transmission. Berger A; Doerr HW; Scharrer I; Weber B J Med Virol; 1997 Sep; 53(1):25-30. PubMed ID: 9298728 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus infection in Italian patients with hypogammaglobulinemia. Quinti I; Pandolfi F; Paganelli R; Giovannetti A; Sacco G; Oliva A; Aiuti F Clin Ther; 1996; 18 Suppl B():96-107. PubMed ID: 8930447 [TBL] [Abstract][Full Text] [Related]
14. Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward. Allander T; Gruber A; Naghavi M; Beyene A; Söderström T; Björkholm M; Grillner L; Persson MA Lancet; 1995 Mar; 345(8950):603-7. PubMed ID: 7898176 [TBL] [Abstract][Full Text] [Related]
15. Epidemiologic survey and genetic analysis of endemic hepatitis C virus infection in a Japanese town with a high prevalence of hepatitis B virus carriers. Tawaraya H; Ohkoshi S; Kuwana K; Watanabe M; Kamimura T; Asakura H J Med Virol; 1995 Apr; 45(4):367-72. PubMed ID: 7545207 [TBL] [Abstract][Full Text] [Related]
16. Anti-HCV seroconversion in multitransfused and immunocompromised patients. A long-term longitudinal study. Cornu C; Brusselmans C; Geubel A; Ferrant A; Cornu G Vox Sang; 1994; 67(3):286-90. PubMed ID: 7532342 [TBL] [Abstract][Full Text] [Related]
17. Characterization of antibody response to hepatitis C virus protein E2 and significance of hypervariable region 1-specific antibodies in viral neutralization. Zibert A; Dudziak P; Schreier E; Roggendorf M Arch Virol; 1997; 142(3):523-34. PubMed ID: 9349298 [TBL] [Abstract][Full Text] [Related]
19. Virological features of hepatitis C virus infection in patients with liver diseases in the inshore area of the Yangtze River. Yao DF; Horie C; Horie T; Shimizu I; Meng XY; Ito S Tokushima J Exp Med; 1994 Jun; 41(1-2):49-56. PubMed ID: 7524191 [TBL] [Abstract][Full Text] [Related]
20. Risk of immune thrombocytopenic purpura and autoimmune hemolytic anemia among 120 908 US veterans with hepatitis C virus infection. Chiao EY; Engels EA; Kramer JR; Pietz K; Henderson L; Giordano TP; Landgren O Arch Intern Med; 2009 Feb; 169(4):357-63. PubMed ID: 19237719 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]